TIM-3 regulates the proliferation by BDNF-mediated PI3K/AKT axis in the process of endometriosis

  • Mol Med. 2023 Dec 19;29(1):170. doi: 10.1186/s10020-023-00768-6.
Wei Tian  1  2 ,  Min Liu  #  2 ,  Yuqiu Liu  #  1 ,  Qingfeng Lv  #  3 ,  HuaFeng Cheng  1 ,  Yanling Gu  1 ,  Mingjiang Li  4
Affiliations
  • 1. Department of Gynecology, Shandong Provincial Hospital Affiliated to Shandong First Medical University, Jinan, Shandong, China.
  • 2. Medical Science and Technology Innovation Center, Shandong First Medical University, Jinan, China.
  • 3. Department of Obstetrics, Shandong Provincial Hospital Affiliated to Shandong First Medical University, Jinan, Shandong, China.
  • 4. Department of Gynecology, Shandong Provincial Hospital Affiliated to Shandong First Medical University, Jinan, Shandong, China. [email protected].
  • # Contributed equally.
PMID: 38114892 DOI: 10.1186/s10020-023-00768-6
Abstract

Background: T cell immunoglobulin and Mucin domain-containing molecule-3 (TIM-3) initially discovered on the surface of Th1 cells, negatively regulates immune responses and mediates Apoptosis of Th1 cells. An increasing number of studies have since shown that TIM-3 is crucial in the genesis and development of immune diseases, cancers, and chronic infectious illnesses. However, the effect of TIM-3 on endometriosis is still unknown.

Methods: Quantitative real-time polymerase chain reaction, western blotting, and immunohistochemistry were used to measure TIM-3 levels in endometriosis. Cell Counting Kit-8, 5-ethynyl-2'-deoxyuridine, colony-forming, Transwell® migration, Matrigel® invasion, and flow cytometry assays were used to explore the function of TIM-3 in vitro, and xenograft experiments in nude mice were used to assess its role in vivo. According to the RNA seq, brain-derived neurotrophic factor (BDNF) was screened. The involvement of specific proliferation-related signaling molecules was determined by transfecting a plasmid and adding an inhibitor in vivo and in vitro.

Results: TIM-3 mRNA and protein expression levels were significantly higher in eutopic and ectopic endometrial tissues than in normal endometrial tissues. By examining the effects of TIM-3 overexpression and knockdown on cell proliferation, migration, and invasion in vitro, and lesions formation in vivo, we found that the expression of TIM-3 was positively correlated with cell proliferation and clone formation in vitro, as well as lesions growth in nude mice. By adding the phosphatidylinositol 3 kinase/protein kinase B(PI3K/Akt) pathway inhibitor LY294002 and knocking down PI3K, we further verified that TIM-3 promotes proliferation in vivo and in vitro via the PI3K pathway. By transfecting the plasmid into ESC cells and gave inhibitors to endometriotic rats models, we tested that TIM-3 regulates the proliferation by BDNF-mediated PI3K/Akt axis.

Conclusion: TIM-3 can promote the proliferation of endometriosis by BDNF-mediated PI3K/Akt axis in vivo and in vitro, which may provide a new therapeutic target for the treatment of endometriosis.

Keywords
Brain-derived neurotrophic factor; Endometrial stromal cells; Endometriosis; LY294002; PI3K/AKT; Proliferation; T cell immunoglobulin and mucin domain-containing molecule-3; Transcriptome sequencing technique.
Products